Stay updated on APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial

Sign up to get notified when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:45:07.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the study details related to the safety, tolerability, efficacy, and pharmacokinetics of APL-2 in patients with warm Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD). This change may reflect new information or findings in the ongoing clinical trial research for these medical conditions.
    Difference
    0.1%
    Check dated 2024-06-06T14:48:13.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying age, weight, health conditions, and prior treatments required for subjects. Previously, no information was provided about the participation criteria.
    Difference
    42%
    Check dated 2024-05-22T21:30:22.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:28:50.000Z thumbnail image

Stay in the know with updates to APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.